Searched for
USFDA PLANT
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspectionZydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 an...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Sun Pharma tanks 3% on surprise USFDA visit to Dadra plantThe stock fell 2.69% to hit a low of Rs 668 on BSE.
- USFDA issues warning letter to Wockhardt's Ankleshwar plantUSFDA has already banned import of products from the facility into the US market since August 5, 2016.
- USFDA finds minor violations at Lupin's Dabhasa plantDrug firm Lupin today said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in Gujarat.
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Torrent Pharma gets establishment nod from USFDAWith the approval, this plant is now the third plant of Torrent Pharma to receive USFDA approval, out of its 5 manufacturing plants.
- Alkem stock up 5% as its Gujarat unit gets USFDA nodShares of Alkem Labs today went up by over 5 per cent after the company said one of its manufacturing plants in Gujarat has obtained establ...
- Alkem's Mandva plant gets establishment nod from USFDAAlkem Labs Ltd today said one of its manufacturing plants in Gujarat has obtained the Establishment Inspection Report (EIR) "approval" from...
- Sharon receives EIR report from USFDA on inspection closureSharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its Dehradun ...
- Ranbaxy Laboratories recalls 29,790 packs of anti-allergy drug in USRanbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to de...
- USFDA to hold workshops across India on quality requirementsUSFDA plans to conduct workshops across India in the next one year in order to sanitise Indian drug cos about the changing quality requirem...
- USFDA pulls up Smruthi Organics for norms violation in unitSmruthi Organics today said it has received a notification from the USFDA highlighting violations of manufacturing norms at its Solapur pla...
- Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDaiichi Sankyo will work with US authorities to resolve issue of a ban imposed by USFDA on import of drugs from Mohali plant of Ranbaxy.
- Wockhardt gets warning letter from USFDA over Waluj plantWockhardt said it has received a warning letter from US health regulator over its facility at Waluj in Maharashtra not meeting manufacturin...
- Ranbaxy units face FDA heat after inspectionsSources said that USFDA has given a ‘not approved’ rating to new products manufactured at the facility, although this could not be independ...
Load More
